2001
Language regression in childhood.
Shinnar S, Rapin I, Arnold S, Tuchman R, Shulman L, Ballaban-Gil K, Maw M, Deuel R, Volkmar F. Language regression in childhood. Pediatric Neurology 2001, 24: 183-9. PMID: 11301218, DOI: 10.1016/s0887-8994(00)00266-6.Peer-Reviewed Original ResearchMeSH KeywordsBrainChildChild Behavior DisordersChild LanguageChild, PreschoolCognition DisordersElectroencephalographyFemaleHumansInfantLandau-Kleffner SyndromeLanguage DisordersLanguage TestsMagnetic Resonance ImagingMaleProspective StudiesRegression, PsychologySeverity of Illness IndexTomography, Emission-Computed, Single-PhotonVerbal BehaviorConceptsYears of ageLanguage regressionAutistic regressionMajor medical centersMonths of ageClinical characteristicsEpileptic aphasiaSpecialist referralMean ageElectroencephalogram abnormalitiesMedical CenterEarly identificationMost childrenSeizuresMean timeAutistic featuresAgeAutistic behaviorChildrenLanguage functionReferralMonthsRegressionPatientsYears
1996
A Double-blind, Placebo-Controlled Study of Fluvoxamine in Adults With Autistic Disorder
McDougle C, Naylor S, Cohen D, Volkmar F, Heninger G, Price L. A Double-blind, Placebo-Controlled Study of Fluvoxamine in Adults With Autistic Disorder. JAMA Psychiatry 1996, 53: 1001-1008. PMID: 8911223, DOI: 10.1001/archpsyc.1996.01830110037005.Peer-Reviewed Original ResearchConceptsStudy of FluvoxamineAutistic disorderSelective serotonin uptake inhibitorAdverse cardiovascular eventsPlacebo-controlled trialWeeks of treatmentSerotonin uptake inhibitorSerotonin neurotransmitter systemShort-term treatmentCardiovascular eventsPlacebo groupMild sedationNeurotransmitter systemsTreatment responseSafe drugUptake inhibitorFluvoxamineSymptoms of autismFluvoxamine maleateDisordersPlaceboAutistic behaviorPatientsAdultsSymptoms
1994
Lithium Augmentation of Fluvoxamine in Autistic Disorder: A Case Report
EPPERSON C, McDOUGLE C, ANAND A, MAREK G, NAYLOR S, VOLKMAR F, COHEN D, PRICE L. Lithium Augmentation of Fluvoxamine in Autistic Disorder: A Case Report. Journal Of Child And Adolescent Psychopharmacology 1994, 4: 201-207. DOI: 10.1089/cap.1994.4.201.Peer-Reviewed Original ResearchSerotonin uptake inhibitorLithium augmentationUptake inhibitorAutistic disorderMinimal clinical responseSubstantial clinical improvementWeeks of treatmentSingle case reportsSignificant adverse effectsClinical improvementClinical responseClinical evidenceCase reportSerotonin functionFluvoxamineMeaningful improvementsTreatment of autismPatientsMarked reductionRating ScaleAdverse effectsRelative efficacyDisordersWeeksTreatment
1984
EEG Abnormalities in Tourette's Syndrome
VOLKMAR F, LECKMAN J, DETLOR J, HARCHERIK D, PRICHARD J, SHAYWITZ B, COHEN D. EEG Abnormalities in Tourette's Syndrome. Journal Of The American Academy Of Child & Adolescent Psychiatry 1984, 23: 352-353. PMID: 6588127, DOI: 10.1016/s0002-7138(09)60516-1.Peer-Reviewed Original Research
1981
Group therapy in the management of manic-depressive illness.
Volkmar F, Bacon S, Shakir S, Pfefferbaum A. Group therapy in the management of manic-depressive illness. American Journal Of Psychotherapy 1981, 35: 226-34. PMID: 7258419, DOI: 10.1176/appi.psychotherapy.1981.35.2.226.Peer-Reviewed Original ResearchConceptsWeeks of hospitalizationLithium maintenance treatmentMaintenance treatmentLithium prophylaxisBipolar manic-depressive patientsLong-term therapy groupGroup of patientsMajor treatment modalityManic-depressive patientsBipolar affective illnessManic-depressive illnessCost-effective adjunctTwo-year periodLithium maintenanceTreatment modalitiesAffective illnessTherapy groupPatientsPoor candidatesIllnessGroup therapyHospitalizationProphylaxisTreatmentPsychotherapy group